Boswellia works through unique pathways in the body. BosMed 500 features an advanced form of boswellia that can support your health in ways that many other forms of boswellia cannot.

BosMed 500

• Features clinically studied, uniquely standardized boswellia
• Up to 10 times more AKBA than unstandardized boswellia
• Safe and effective
• Supports a healthy inflammation response*†

The most advanced Boswellia on the market today!

^{BosPure® is a registered trademark of Dolcas-Biotech, LLC.
†Occasional inflammation due to exercise or overuse}

FAQS:

What is the difference between the boswellia in BosMed 500 and other boswellia extracts?

Most experts consider a compound known as AKBA to be associated with boswellia’s health benefits. The boswellia in BosMed 500 is standardized to greater than 10 percent of this important compound. Additionally, this boswellia contains virtually no β-boswellic acid, which can interfere with the activity of AKBA.

Where is the boswellia in BosMed 500 obtained?

The boswellia used in BosMed 500 is harvested from trees growing in northwest India. The trees are under the supervision of the Department of Forestry, which carefully controls harvest frequency and other issues of sustainability. Many of the sustainability concerns regarding boswellia are associated with a different species of boswellia – Boswellia papyrifera – which is a very fragrant species harvested for use in the perfume and incense industries.

Is your boswellia sustainably sourced?

Yes. The boswellia we use is grown traditionally in India and harvested under the oversight of the Department of Forestry, which carefully controls harvest frequency and other issues of sustainability. The boswellia family contains over 20 species, and each species may be subjected to different sustainability concerns. We only use Boswellia serrata that is sustainably harvested and therefore does not contribute to the problems facing other species of boswellia.